Sustained Effect of Red-light Therapy for Myopia Control: A 2-Year Post-Trial Follow-up Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Myopia
Interventions
DEVICE

Red-light therapy device

Red-light therapy was performed with a low-intensity laser (LD-A, Jilin LD Optoelectronics Technology, Jilin, China) with an irradiance of 0.35 ± 0.02 mW/cm2, a wavelength of 650 nm ± 10 nm, and illumination of approximately 400 lux on average.

DEVICE

Spectacles

Single focus spectacles, that is to say, wearing glasseses with minus power lens

Trial Locations (1)

315000

Ningbo Eye Hospital, Ningbo

All Listed Sponsors
collaborator

Ningbo Eye Hospital

OTHER

lead

Beijing Airdoc Technology Co., Ltd.

INDUSTRY